GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $268,000 | +18.6% | 6,175 | +10.8% | 0.01% | +8.3% |
| Q1 2016 | $226,000 | 0.0% | 5,575 | -0.3% | 0.01% | 0.0% |
| Q4 2015 | $226,000 | +1.8% | 5,590 | -3.2% | 0.01% | 0.0% |
| Q3 2015 | $222,000 | -4.3% | 5,775 | +3.6% | 0.01% | 0.0% |
| Q2 2015 | $232,000 | -9.7% | 5,575 | 0.0% | 0.01% | -14.3% |
| Q1 2015 | $257,000 | +8.0% | 5,575 | 0.0% | 0.01% | +7.7% |
| Q4 2014 | $238,000 | -71.7% | 5,575 | -67.8% | 0.01% | -18.8% |
| Q3 2014 | $842,000 | +155.2% | 17,325 | +180.6% | 0.02% | -15.8% |
| Q2 2014 | $330,000 | -0.6% | 6,175 | -0.5% | 0.02% | -5.0% |
| Q1 2014 | $332,000 | +0.3% | 6,206 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $331,000 | +6.8% | 6,206 | +0.5% | 0.02% | -4.8% |
| Q3 2013 | $310,000 | -8.6% | 6,175 | -8.9% | 0.02% | -12.5% |
| Q2 2013 | $339,000 | – | 6,775 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |